The incidence of allergies in children has increased significantly in the last two decades. Allergies can develop in the first few months of life, evident as nasal congestion, cough, rash or diarrhea following the ingestion of certain foods. Allergies affect all ethnic groups around the world. Allergy is the term used to describe our immunologic sensitivity to an allergen (any substance that causes an allergic reaction).
This sensitisation may occur by inhaling airborne allergens or eating food that contains allergens. The consequence of allergens entering the body is an immune response by producing a special type of antibody IgE and a reaction that causes symptoms and disease in a predisposed person.
The ALLERGYZEN concept is an innovative assay for the determination of IgE Total and IgE Specific tested simultaneously, with common reagents for all parameters.
As ZenTech's vision is to come up with adapted in vitro diagnostic solutions using less or non-invasive sampling methods, the ALLERGYZEN assay is also available using the dried blood spot technique.
ZenTech headquarters are located in LIEGE Science Park, Belgium. We are a biotechnology company highly specialized in the diagnostic of pathologies occurring in the early life stages, from birth to adolescence (newborn, toddler and child) and in the diagnostic of chronic diseases affecting both children and adults.
We have considerable expertise in the development, production and marketing of IVD kits specifically developed for the newborn screening and paediatric use. The techniques are adapted to the requirements of non-invasive assays.
Our specialization is further enhanced by competence in the automation of medical diagnostic laboratory processes.
ZenTech has developed and adapted a number of platforms to automate the use of these kits, according to the tests performed by each laboratory.
Our high-quality products are marketed either directly or through distributors and OEM agreements worldwide.